Log In
BCIQ
Print this Print this
 

Anya, Lybrel, levonorgestrel/estradiol

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionOral fixed-dose combination of low-dose levonorgestrel and ethinyl estradiol
Molecular Target Estrogen receptor 1 (ESR1) ; Progesterone receptor (PGR)
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today